Empowering Researchers, Transforming Science

Building a vibrant ecosystem that connects researchers, clinicians, and innovators to transform the future of health and medical science.
Resources
What’s happening?

Empowering Researchers, Transforming Science

Building a vibrant ecosystem that connects researchers, clinicians, and innovators to transform the future of health and medical science.
Resources
What’s happening?

Empowering Researchers, Transforming Science

Building a vibrant ecosystem that connects researchers, clinicians, and innovators to transform the future of health and medical science.
Resources
What’s happening?

Welcome to the NUSMedSci Alliance Community

The NUSMedSci Alliance is a collaborative initiative that unites researchers, clinicians, and faculty members across NUS Medicine and beyond. We are dedicated to supporting impactful research partnerships, nurturing young investigators, and enabling innovation through shared expertise and resources.

Learn More
Join

Please register to join NUSMedSci Alliance WhatsApp Chatgroup, via the above link. Subject to approval.

Explore Our Featured Initiatives and Programmes

Translational Research Programmes

Bridging discovery and application — fostering partnerships between researchers and clinicians to accelerate real-world impact.
Find Out More

Researchers Highlight

Spotlighting inspiring researchers across NUS Medicine who are advancing innovation and improving lives through science.
Find Out More

Collaborative Networks for Research Excellence

Connecting talent, expertise, and resources across disciplines to nurture impactful collaborations and scientific breakthroughs.
Find Out More

Featured Events

Join our latest events to connect, learn, and collaborate with the NUSMedSci Alliance community.

  • Friday, 28 November 2025, 5.30pm – 7.30pm
  • CRC Auditorium, MD11, NUS Yong Loo Lin School of Medicine, 10 Medical Drive, Singapore 117597

NUSMED INSPIRE120 Professorial Lecture: Commemorating 120 Years of Inspiring Health for All

Speaker
Professor Chong Yap Seng
Discover how medical research can influence national health policy and promote equity in healthcare.
See more
  • 26 November 2025, 12:30pm - 01:30pm
  • NUHS Tower Block T11-02

The Editorial Process at Nature Metabolism

Speaker
Dr Revati Dewal
This talk covers how the submission process at Nature Metabolism works, things to keep in mind when submitting, the journal's scope, as well as tips and tricks to give your submission the best chance.
See more
  • Tue 8 Jul 2025
  • MD11 Auditorium

NUS Medicine Graduate Students Townhall

Speaker
A/Prof Kevin Tan and Prof Roger Foo
An engagement cum dialogue for NUS Medicine graduate students with Division of Graduate Studies (DGS) and Research Office (RO).
See more
  • Sat 28 Jun 2025
  • Health District @ Queenstown

NUSMedSci Alliance Brew

Speaker
Dr Leon Ooi and Dr Ru Kong
Healing minds with AI: how technology is transforming mental health care.
See more
  • Fri 20 Jun 2025
  • Health District @ Queenstown

NUSMedSci Alliance Brew

Speaker
Redirecting immune, lipid and metabolic drivers of early cardiovascular diseases
See more
  • Sat 31 May 2025
  • Tampines Regional Library

NUSMedSci Alliance Brew

Speaker
Dr Daniel Teh
Illuminating Health: The Science of Light and Ageing.
See more
View all

Latest News

Stay informed about our latest initiatives

Graduate Students Townhall

Graduate students engaged in meaningful conversations about research growth and future collaboration.
Read More

NRF CRP Grantsmanship workshop

The Alliance’s workshop equipped participants with the skills to craft compelling research proposals for large-scale grants.
Read More

Launch of the NUSMedSci Alliance: Empowering Research and Transforming Science

A new chapter begins for NUS Medicine with the establishment of the NUSMedSci Alliance, fostering collaboration and innovation across research disciplines.
Read More
View all
NUS Medicine News

Join our newsletter to stay up to date on features and releases.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Be part of our community

Register for the NUSMedSci Alliance WhatsApp chatgroup using the link above. Admission is subject to approval.

Apply now

Dr Yu Haojie

Assistant Professor

Dept of Biochemistry

Precision Medicine

Research Interests:

 

My lab at NUS aims to establish an integrative and systematic approach to uncover novel regulators of cardiometabolic diseases by leveraging human GWAS data, cell type-specific eQTL, single-nucleus RNA sequencing & chromatin accessibility profiling, and CRISPR/Cas9-based functional screening.
In addition, we have a strong focus on GPCRs and their roles in disease regulation. To advance therapeutic development, we utilize high-throughput compound screening and AI-driven ‘hit-to-lead’ optimisation to identify and refine novel GPCR-targeting therapies.

Potential Clinical Partnership:

 

We seek to collaborate with clinician to acquire patient-derived
samples (plaques and liver) for single-nucleus RNA sequencing
and chromatin accessibility profiling.

Read More
Linkedin-in

Dr Yeo Shang Long

Assistant Professor

Centre for Biomedical Ethics

Programmes:

Research Interests:

  • Ethics of nudging, ethics of behaviour change
  • Clinical ethics
  • Ethics of public policy
  • Ethics of AI

Potential Clinical Partnership:

  • Opportunities to analyse clinical cases that are unique to Singaporean/Asian context (e.g. about role of family, role of religious values etc.)
  • Opportunities to test and ethically evaluate various interventions in clinical context (e.g. AI summarization, nudges to take up screening/treatment)
Read More
Linkedin-in

Dr Vincenzo Sorrentino

Assistant Professor

Dept of Biochemistry

Healthy Longevity

Research Interests:

My laboratory focuses on: -Biology of aging; -Proteostasis; – Mitochondria and NAD+ metabolism; – Preclinical models of neuromuscular disease (e.g. C. elegans, cell lines, rodents).

Potential Clinical Partnership:

 

  • Access to clinical samples for analyses of NAD+ metabolites in different cohorts (e.g. elderlies, chronic diseases)
  • Observatory studies linking energy metabolites to clinical phenotypes
  • Pilot/Intervention studies in humans with novel NAD+ precursors studied in my lab
Read More
Linkedin-in

Dr Tsai Shih-Yin

Assistant Professor

Dept of Physiology

Healthy Longevity TRP

Research Interests:

  • mTORC1 signaling and muscle aging: Understanding how mTORC1 pathway disrupts proteostasis and contributes to sarcopenia.
  • Sex differences in muscle aging: Investigating how biological sex influences proteostasis mechanisms and responses to anti-aging interventions.

Potential Clinical Partnership:

One area where collaboration would be particularly impactful is the
development of a non-invasive biomarker for mTORC1-associated
sarcopenia. This project would aim to:

  • Identify circulating factors (e.g., plasma proteins, miRNAs, metabolites) that reflect mTORC1 activity and proteostasis status in skeletal muscle.
  • Correlate these biomarkers with muscle strength, composition, and functional assessments in older adults.
  • Lay the groundwork for early detection tools and monitoring response to targeted therapies, such as mTORC1 inhibitors or proteostasis enhancers.
Read More
Linkedin-in

Dr Tan Chee Wah

Research Assistant Professor

Dept of Microbiology and Immunology

Infectious Diseases TRP

Research Interests:


My lab focuses primarily on pandemic sciences, with a particular interest in ‘bat viruses’ and ‘antibodies.’ Our team leverages surrogate systems to accurately quantify neutralizing antibodies, which are key immune biomarkers responsible for protection against viral diseases. Through surveillance, we aim to identify infectious disease threats in the region and better prepare for future pandemics, including the development of universal vaccines and therapeutic antibodies.

Potential Clinical Partnership:

 

To understand the correlates of protection, we aim to analyze
clinical samples from patients infected with respiratory diseases,
such as RSV and influenza viruses.

Read More
Linkedin-in

Dr Shi Jiahai

Assistant Professor

Dept of Biochemistry

Synthetic Biology TRP

Research Interests:

  • Red Blood Cell maturation and ageing, aiming for thalassemia treatment
  • Red Blood Cell & Synthetic RBC therapy against anemia, autoimmune diseases, and cancers
  • Non-viral gene therapy delivered by Red Blood Cell extracellular vesicle
  • Al-Assisted Antibody Discovery

Potential Clinical Partnership:

  • RBC Therapy against Type 1 Diabetes (T1D)
  • Type Specific Blood Inventory Management
  • Thalassemia Therapy Development
  • Extended Blood Typing Technology
  • Gene Therapy against Metabolic Disorders
  • Al-Assisted Antibody Discovery for diagnostics and targeted therapies
Read More
Linkedin-in

Dr Jiao Chunlei

Assistant Professor

Dept of Biological Sciences

Synthetic Biology TRP

Research Interests:

Discovery, engineering, and design of CRISPR and novel bacterial defense systems with the aim of developing innovative platforms for disease diagnosis and treatment.

  1. Mine and characterize new CRISPR or other novel defense systems
  2. Develop a sensitive and high-throughput RNA detection platform
  3. Develop a precise and highly efficient knock-in platform in eukaryotic cells
  4. Develop a precise and non-cytotoxic RNA knock-down platform
  5. Develop a long-range genome knock-out platform
  6. Develop a spatial, sequential RNA recording platform

Potential Clinical Partnership:


Our laboratory develops technologies for practical clinical applications, such as the DNA microarray-based multiplex disease detection platform, which relies on collaboration with clinicians to obtain patient samples—including those from sepsis cases. Additionally, our large-scale gene insertion research in eukaryotic cells, relevant to CAR-T cell therapy, underscores the importance of clinician partnerships.

Read More
Linkedin-in

A/Prof Chris Sham Lok

Associate Professor

Dept of Microbiology and Immunology

IDTRP

Research Interests:

Our research program explores the molecular mechanisms that underpin capsule synthesis and bacterial virulence. We sought to:

Investigate how cell-surface glycans shape pathogenicity and immune responses.

Elucidate the interplay of capsule assembly, cell envelope synthesis, and cell division.

Uncover the mechanism behind enzyme specificity that ensures the fidelity of glycan synthesis.

Innovate high-throughput systems biology methods, such as Dual Tn-seq, to map genetic interactions and define gene functions.

Potential Clinical Partnership:

 

We seek clinical scientists specializing in vaccinology, infection biology,

and epidemiology to partner with us to explore captivating biological

questions and address unmet medical needs.

Read More
Linkedin-in

Dr Alan Prem Kumar

Research Assistant Professor

Pharmacology

NUS Cancer for Cancer Research (N2CR)

Research Interests:

 

At the NUS Yong Loo Lin School of Medicine, my research is dedicated to advancing precision oncology in breast and gynecological cancers by targeting nuclear receptor signaling and RNA helicases. By identifying predictive biomarkers and developing targeted therapeutics, my work aims to enhance drug efficacy, personalize treatment strategies, and ultimately improve patient survival and quality of life.

Potential Clinical Partnership:

 

  1. Enhancing Immunogenicity in Triple-Negative Breast Cancer (TNBC): Our in-house drug development program focuses on modulating the tumor microenvironment to boost immunogenicity in TNBC.
  2. Biomarker-Driven Optimization of Platinum Therapy in Ovarian Cancer: We are translating the clinical relevance of a key biomarker to refine patient selection for platinum-based therapies in ovarian cancer.
Read More
Linkedin-in

A/Prof Teo Kee Keong, Adrian

Associate Professor

Dept of Biochemistry

Dept of Medicine

Research Interests:

  • Stem cells
  • Diabetes
  • Pancreatic beta cells
  • Organoids
  • Precision medicine
  • Cell therapy

Potential Clinical Partnership: 

  • Insulin insufficiency 
  • Transplantation therapy 
  • Diabetes complications 
  • Cell therapy 
  • Clinical trials 
Read More
Linkedin-in